K-numberK251812
Device nameSteripath® Flow™ Blood Collection System
ApplicantMagnolia Medical Technologies
Product codeJKA
Device classClass II
Decision dateSep 25, 2025
DecisionSubstantially Equivalent
Regulation862.1675
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Steripath® Flow™ Blood Collection System is a blood collection system designed to draw blood for in vitro diagnostic testing. It diverts and sequesters the initial specimen prior to collection of a subsequent test sample to reduce blood culture contamination. Components of the system may also be used for infusion following sample collection after disconnection of the Initial Specimen Diversion Device (ISDD).

Technological characteristics

Not stated in this summary.

Test standards cited

Not stated.

Substantial equivalence argument

The device is indicated for blood collection with an initial specimen diversion feature to reduce contamination in blood cultures. The substantial equivalence determination is based on comparison to predicate blood specimen collection devices that are legally marketed, with the diversion mechanism representing a design variation that does not raise new questions of safety or effectiveness relative to standard blood collection procedures.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →